Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Ian Pollack
Phase I Study of SU5416, a Small Molecule Inhibitor of the Vascular Endothelial Growth Factor Receptor (VEGFR) in Refractory Pediatric Central Nervous System Tumors
Pediatric Blood and Cancer
Oncology
Child Health
Hematology
Perinatology
Medicine
Pediatrics
Related publications
Phase II Study of SU5416, a Small Molecule Vascular Endothelial Growth Factor Tyrosine Kinase Receptor Inhibitor, in Patients With Refractory Multiple Myeloma
Clinical Cancer Research
Cancer Research
Oncology
A Phase I Study of Foretinib, a Multi-Targeted Inhibitor of C-Met and Vascular Endothelial Growth Factor Receptor 2
Clinical Cancer Research
Cancer Research
Oncology
Expression of the Vascular Endothelial Growth Factor C Receptor VEGFR-3 in Lymphatic Endothelium of the Skin and in Vascular Tumors
American Journal of Pathology
Forensic Medicine
Pathology
Vascular Endothelial Growth Factor-C and Its Receptor VEGFR-3 in the Nasal Mucosa and in Nasopharyngeal Tumors
American Journal of Pathology
Forensic Medicine
Pathology
Tumors of the Pediatric Central Nervous System
Journal of Neuro-Ophthalmology
Medicine
Ophthalmology
Neurology
Vascular Endothelial Growth Factor Receptor Inhibitor SU5416 Suppresses Lymphocyte Generation and Immune Responses in Mice by Increasing Plasma Corticosterone
PLoS ONE
Multidisciplinary
Morphological Spectrum of Pediatric Central Nervous System Tumors- A Seven Year Study From Central India
Journal of Medical Science And clinical Research
Liquid Biopsy for Pediatric Central Nervous System Tumors
npj Precision Oncology
Nephrotic Syndrome Unfavorable Course Correlates With Downregulation of Podocyte Vascular Endothelial Growth Factor Receptor (VEGFR)-2
Folia Histochemica et Cytobiologica
Medicine
Forensic Medicine
Pathology
Histology